{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:13:55Z","timestamp":1793412835364,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00401-013-1096-7","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T11:30:15Z","timestamp":1360582215000},"page":"753-769","source":"Crossref","is-referenced-by-count":432,"title":["\u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy?"],"prefix":"10.1007","volume":"125","author":[{"given":"Aoife P.","family":"Kiely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine T.","family":"Asi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Limousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Proukakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","volume":"38","author":"Z Ahmed","year":"2012","unstructured":"Ahmed Z, Asi YT, Sailer A et al (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4\u201324","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1096_CR2","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","volume":"4","author":"A Al-Chalabi","year":"2009","unstructured":"Al-Chalabi A, Durr A, Wood NW et al (2009) Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 4:e7114","journal-title":"PLoS One"},{"key":"1096_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz C, Lin W-L, Ahmed Z et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann Neurol 61:435\u2013445","journal-title":"Ann Neurol"},{"key":"1096_CR4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.parkreldis.2006.02.005","volume":"12","author":"RA Armstrong","year":"2006","unstructured":"Armstrong RA, Cairns NJ, Lantos PL (2006) Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes. Parkinsonism Relat Disord 12:356\u2013362","journal-title":"Parkinsonism Relat Disord"},{"key":"1096_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","volume":"65","author":"A Athanassiadou","year":"1999","unstructured":"Athanassiadou A, Voutsinas G, L Psiouri et al (1999) Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am J Hum Genet 65:555\u2013558","journal-title":"Am J Hum Genet"},{"key":"1096_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16:271\u2013278","journal-title":"Neurobiol Aging"},{"key":"1096_CR7","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E (2000) Pathoanatomy of Parkinson\u2019s disease. J Neurol 247:II3\u2013II10","journal-title":"J Neurol"},{"key":"1096_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1096_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-007-0315-5","volume":"115","author":"N Brandmeir","year":"2008","unstructured":"Brandmeir N, Geser F, Kwong L et al (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123\u2013131","journal-title":"Acta Neuropathol"},{"key":"1096_CR10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"M-C Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin M-C, Kachergus J, Roumier C et al (2004) \u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"1096_CR11","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1172\/JCI35314","volume":"119","author":"L Chen","year":"2009","unstructured":"Chen L, Periquet M, Wang X et al (2009) Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest 119:3257\u20133265","journal-title":"J Clin Invest"},{"key":"1096_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-008-0138-0","volume":"9","author":"J Choi","year":"2008","unstructured":"Choi J, Woo M, Ma H-I et al (2008) Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9:263\u2013269","journal-title":"Neurogenetics"},{"key":"1096_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi W, Zibaee S, Jakes R et al (2004) Mutation E46K increases phospholipid binding and assembly into filaments of human \u03b1-synuclein. FEBS Lett 576:363\u2013368","journal-title":"FEBS Lett"},{"key":"1096_CR14","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between A\u03b2, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"1096_CR15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"1096_CR16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/mds.23948","volume":"26","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Gwinn K, Singleton A, Hardy J (2011) Parkinson\u2019s disease and \u03b1-synuclein expression. Mov Disord 26:2160\u20132168","journal-title":"Mov Disord"},{"key":"1096_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00296742","volume":"87","author":"D Dickson","year":"1994","unstructured":"Dickson D, Schmidt M, Lee V, Zhao M-L, Yen S, Trojanowski J (1994) Immunoreactivity profile of hippocampal CA2\/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87:269\u2013276","journal-title":"Acta Neuropathol"},{"key":"1096_CR18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.41.9.1402","volume":"41","author":"DW Dickson","year":"1991","unstructured":"Dickson DW, Ruan D, Crystal H et al (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer\u2019s disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41:1402\u20131409","journal-title":"Neurology"},{"key":"1096_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","volume":"104","author":"J Duda","year":"2002","unstructured":"Duda J, Giasson B, Mabon M et al (2002) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 104:7\u201311","journal-title":"Acta Neuropathol"},{"key":"1096_CR20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of \u03b1-synuclein in its free and lipid-associated states. J Mol Biol 307:1061\u20131073","journal-title":"J Mol Biol"},{"key":"1096_CR21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L et al (2004) Comparison of kindreds with parkinsonism and \u03b1-synuclein genomic multiplications. Ann Neurol 55:174\u2013179","journal-title":"Ann Neurol"},{"key":"1096_CR22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","volume":"68","author":"J Fuchs","year":"2007","unstructured":"Fuchs J, Nilsson C, Kachergus J et al (2007) Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68:916\u2013922","journal-title":"Neurology"},{"key":"1096_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N et al (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"1096_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2990.2010.01136.x","volume":"37","author":"F Geser","year":"2011","unstructured":"Geser F, Malunda JA, Hurtig HI et al (2011) TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol 37:358\u2013365","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1096_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","volume":"4","author":"B Giasson","year":"2003","unstructured":"Giasson B, Lee V, Trojanowski J (2003) Interactions of amyloidogenic proteins. Neuromolecular Med 4:49\u201358","journal-title":"Neuromolecular Med"},{"key":"1096_CR26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.410270309","volume":"27","author":"LI Golbe","year":"1990","unstructured":"Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson\u2019s disease. Ann Neurol 27:276\u2013282","journal-title":"Ann Neurol"},{"key":"1096_CR27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s004010051177","volume":"99","author":"K Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy K, Mehta ND, Farrer M et al (2000) Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 99:663\u2013672","journal-title":"Acta Neuropathol"},{"key":"1096_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","volume":"122","author":"G Halliday","year":"2011","unstructured":"Halliday G, Holton J, Revesz T, Dickson D (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 122:187\u2013204","journal-title":"Acta Neuropathol"},{"key":"1096_CR29","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1021\/ja210866j","volume":"134","author":"M Hejjaoui","year":"2012","unstructured":"Hejjaoui M, Butterfield S, Fauvet B et al (2012) Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: \u03b1-synuclein phosphorylation at tyrosine 125. J Am Chem Soc 134:5196\u20135210","journal-title":"J Am Chem Soc"},{"key":"1096_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi S, Iseki E, Yamamoto R et al (2007) Concurrence of TDP-43, tau and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res 1184:284\u2013294","journal-title":"Brain Res"},{"key":"1096_CR31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez P, Bonnet AM, D\u00e9barges B et al (2004) Causal relation between \u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1169\u20131171","journal-title":"Lancet"},{"key":"1096_CR32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archneur.65.4.514","volume":"65","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A et al (2008) Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 65:514\u2013519","journal-title":"Arch Neurol"},{"key":"1096_CR33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010050655","volume":"93","author":"M Inoue","year":"1997","unstructured":"Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93:585\u2013591","journal-title":"Acta Neuropathol"},{"key":"1096_CR34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irizarry","year":"1998","unstructured":"Irizarry MC, Growdon W, Gomez-Isla T et al (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson\u2019s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334\u2013337","journal-title":"J Neuropathol Exp Neurol"},{"key":"1096_CR35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1440-1789.2003.00530.x","volume":"24","author":"E Iseki","year":"2004","unstructured":"Iseki E (2004) Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson\u2019s disease or Alzheimer\u2019s disease. Neuropathology 24:72\u201378","journal-title":"Neuropathology"},{"key":"1096_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330","journal-title":"Mov Disord"},{"key":"1096_CR37","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo E, McLaurin J, Yip CM, St. George-Hyslop P, Fraser PE (2000) \u03b1-Synuclein membrane interactions and lipid specificity. J Biol Chem 275:34328\u201334334","journal-title":"J Biol Chem"},{"key":"1096_CR38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hipo.20212","volume":"16","author":"FC Joelving","year":"2006","unstructured":"Joelving FC, Billeskov R, Christensen JR, West M, Pakkenberg B (2006) Hippocampal neuron and glial cell numbers in Parkinson\u2019s disease\u2014a stereological study. Hippocampus 16:826\u2013833","journal-title":"Hippocampus"},{"key":"1096_CR39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","volume":"3","author":"PJ Kahle","year":"2002","unstructured":"Kahle PJ, Neumann M, Ozmen L et al (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3:583\u2013588","journal-title":"EMBO Rep"},{"key":"1096_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1750-3639.2011.00509.x","volume":"22","author":"T Kanazawa","year":"2012","unstructured":"Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature \u03b1-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22:67\u201378","journal-title":"Brain Pathol"},{"key":"1096_CR41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","volume":"18","author":"T Kanazawa","year":"2008","unstructured":"Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites\u2014three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415\u2013422","journal-title":"Brain Pathol"},{"key":"1096_CR42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-0004.2007.00781.x","volume":"71","author":"CS Ki","year":"2007","unstructured":"Ki CS, Stavrou EF, Davanos N et al (2007) The Ala53Thr mutation in the \u03b1-synuclein gene in a Korean family with Parkinson disease. Clin Genet 71:471\u2013473","journal-title":"Clin Genet"},{"key":"1096_CR43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T et al (1998) Ala30Pro mutation in the gene encoding [alpha]-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"1096_CR44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"1096_CR45","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","volume":"49","author":"CA Lasagna-Reeves","year":"2010","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Jackson GR, Kayed R (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry (Mosc) 49:10039\u201310041","journal-title":"Biochemistry (Mosc)"},{"key":"1096_CR46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2004.01.007","volume":"27","author":"VMY Lee","year":"2004","unstructured":"Lee VMY, Giasson BI, Trojanowski JQ (2004) More than just two peas in a pod: common amyloidogenic properties of tau and \u03b1-synuclein in neurodegenerative diseases. Trends Neurosci 27:129\u2013134","journal-title":"Trends Neurosci"},{"key":"1096_CR47","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1074\/jbc.M111.306902","volume":"287","author":"LR Lemkau","year":"2012","unstructured":"Lemkau LR, Comellas G, Kloepper KD, Woods WS, George JM, Rienstra CM (2012) Mutant protein A30P \u03b1-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J Biol Chem 287:11526\u201311532","journal-title":"J Biol Chem"},{"key":"1096_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou K, Dickson D, McComb R et al (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Acta Neuropathol 116:25\u201335","journal-title":"Acta Neuropathol"},{"key":"1096_CR49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.2004.046425","volume":"76","author":"AW Michell","year":"2005","unstructured":"Michell AW, Barker RA, Raha-Chowdhury R, Raha SK (2005) A case of late onset sporadic Parkinson\u2019s disease with an A53T mutation in \u03b1-synuclein. J Neurol Neurosurg Psychiatry 76:596\u2013597","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1096_CR50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s004010050761","volume":"95","author":"T Mizutani","year":"1997","unstructured":"Mizutani T, Inose T, Nakajima S et al (1997) Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol 95:15\u201327","journal-title":"Acta Neuropathol"},{"key":"1096_CR51","unstructured":"Mizutani T, Mitsui J, Ozawa T et al (2009) Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies\u2014further observations. In: Clinicopathological conference on dementia with Lewy bodies and Parkinson\u2019s disease dementia: symposium 5. News from neuropathology of DLB and PDD 08.03.2009\u201310.03.2009"},{"key":"1096_CR52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-007-0316-4","volume":"115","author":"F Mori","year":"2008","unstructured":"Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) \u03b1-Synuclein pathology in the neostriatum in Parkinson\u2019s disease. Acta Neuropathol 115:453\u2013459","journal-title":"Acta Neuropathol"},{"key":"1096_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221\u2013229","journal-title":"Acta Neuropathol"},{"key":"1096_CR54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1096\/fj.01-0517fje","volume":"16","author":"A Negro","year":"2002","unstructured":"Negro A, Brunati AM, Donella-Deana A, Massimino ML, Pinna LA (2002) Multiple phosphorylation of \u03b1-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J 16:210\u2013212","journal-title":"FASEB J"},{"key":"1096_CR55","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","volume":"59","author":"K Nishioka","year":"2006","unstructured":"Nishioka K, Hayashi S, Farrer MJ et al (2006) Clinical heterogeneity of \u03b1-synuclein gene duplication in Parkinson\u2019s disease. Ann Neurol 59:298\u2013309","journal-title":"Ann Neurol"},{"key":"1096_CR56","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/humu.21007","volume":"30","author":"K Nuytemans","year":"2009","unstructured":"Nuytemans K, Meeus B, Crosiers D et al (2009) Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum Mutat 30:1054\u20131061","journal-title":"Hum Mutat"},{"key":"1096_CR57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/01.wnl.0000299387.59159.db","volume":"70","author":"T Obi","year":"2008","unstructured":"Obi T, Nishioka K, Ross OA et al (2008) Clincopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology 70:238\u2013241","journal-title":"Neurology"},{"key":"1096_CR58","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657\u20132671","journal-title":"Brain"},{"key":"1096_CR59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.52.3.651","volume":"52","author":"A Papadimitriou","year":"1999","unstructured":"Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I (1999) Mutated \u03b1-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 52:651","journal-title":"Neurology"},{"key":"1096_CR60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79\u2013100","journal-title":"J Neurol Sci"},{"key":"1096_CR61","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"M Polymeropoulos","year":"1997","unstructured":"Polymeropoulos M, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"1096_CR62","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","volume":"274","author":"MH Polymeropoulos","year":"1996","unstructured":"Polymeropoulos MH, Higgins JJ, Golbe LI et al (1996) Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23. Science 274:1197\u20131199","journal-title":"Science"},{"key":"1096_CR63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03033778","volume":"7","author":"DL Pountney","year":"2005","unstructured":"Pountney DL, Treweek TM, Chataway T et al (2005) Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res 7:77\u201385","journal-title":"Neurotox Res"},{"key":"1096_CR64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00401-007-0262-1","volume":"114","author":"A Probst","year":"2007","unstructured":"Probst A, Taylor K, Tolnay M (2007) Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 114:335\u2013345","journal-title":"Acta Neuropathol"},{"key":"1096_CR65","doi-asserted-by":"crossref","unstructured":"Proukakis C, Dudzik CG, Breier T et al (2012) A novel alpha-synuclein missense mutation in Parkinson\u2019s disease. Neurology (in press)","DOI":"10.1212\/WNL.0b013e31828727ba"},{"key":"1096_CR66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","volume":"15","author":"A Puschmann","year":"2009","unstructured":"Puschmann A, Ross OA, Vilari\u00f1o-G\u00fcell C et al (2009) A Swedish family with de novo \u03b1-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat Disord 15:627\u2013632","journal-title":"Parkinsonism Relat Disord"},{"key":"1096_CR67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.870020201","volume":"2","author":"N Quinn","year":"1987","unstructured":"Quinn N, Critchley P, Marsden CD (1987) Young onset Parkinson\u2019s disease. Mov Disord 2:73\u201391","journal-title":"Mov Disord"},{"key":"1096_CR68","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1529\/biophysj.105.079251","volume":"90","author":"E Rhoades","year":"2006","unstructured":"Rhoades E, Ramlall TF, Webb WW, Eliezer D (2006) Quantification of \u03b1-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. Biophys J 90:4692\u20134700","journal-title":"Biophys J"},{"key":"1096_CR69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12031-009-9190-y","volume":"39","author":"M Riedel","year":"2009","unstructured":"Riedel M, Goldbaum O, Richter-Landsberg C (2009) \u03b1-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. J Mol Neurosci 39:226\u2013234","journal-title":"J Mol Neurosci"},{"key":"1096_CR70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21786","volume":"67","author":"OA Ross","year":"2010","unstructured":"Ross OA, Vilarino-Guell C, Wszolek ZK, Farrer MJ, Dickson DW (2010) Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol 67:414\u2013415","journal-title":"Ann Neurol"},{"key":"1096_CR71","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C et al (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610\u2013614","journal-title":"Ann Neurol"},{"key":"1096_CR72","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.22078","volume":"67","author":"K Seidel","year":"2010","unstructured":"Seidel K, Sch\u00f6ls L, Nuber S et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684\u2013689","journal-title":"Ann Neurol"},{"key":"1096_CR73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-510X(00)00364-6","volume":"179","author":"K Shibuya","year":"2000","unstructured":"Shibuya K, Nagatomo H, Iwabuchi K, Inoue M, Yagishita S, Itoh Y (2000) Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy. J Neurol Sci 179:50\u201358","journal-title":"J Neurol Sci"},{"key":"1096_CR74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2990.2006.00817.x","volume":"33","author":"B Sikorska","year":"2007","unstructured":"Sikorska B, Papierz W, Preusser M, Liberski PP, Budka H (2007) Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies. Neuropathol Appl Neurobiol 33:126\u2013129","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1096_CR75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al (2003) \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"1096_CR76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F","volume":"47","author":"SM Solano","year":"2000","unstructured":"Solano SM, Miller DW, Augood SJ, Young AB, Penney JB (2000) Expression of \u03b1-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson\u2019s disease. Ann Neurol 47:201\u2013210","journal-title":"Ann Neurol"},{"key":"1096_CR77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","volume":"49","author":"PJ Spira","year":"2001","unstructured":"Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA (2001) Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation. Ann Neurol 49:313\u2013319","journal-title":"Ann Neurol"},{"key":"1096_CR78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(97)00336-4","volume":"227","author":"A Takeda","year":"1997","unstructured":"Takeda A, Arai N, Komori T, Kato S, Oda M (1997) Neuronal inclusions in the dentate fascia in patients with multiple system atrophy. Neurosci Lett 227:157\u2013160","journal-title":"Neurosci Lett"},{"key":"1096_CR79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","volume":"33","author":"JQ Trojanowski","year":"2007","unstructured":"Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615\u2013620","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1096_CR80","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer TS, Bax A, Cole NB, Nussbaum RL (2005) Structure and dynamics of micelle-bound human \u03b1-synuclein. J Biol Chem 280:9595\u20139603","journal-title":"J Biol Chem"},{"key":"1096_CR81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP\/\u03b1-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol 99:14\u201320","journal-title":"Acta Neuropathol"},{"key":"1096_CR82","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 67:402\u2013416","journal-title":"J Neuropathol Exp Neurol"},{"key":"1096_CR83","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.21889","volume":"67","author":"JY Yun","year":"2010","unstructured":"Yun JY, Lee WW, Lee JY, Kim HJ, Park SS, Jeon BS (2010) SNCA variants and multiple system atrophy. Ann Neurol 67:554\u2013555","journal-title":"Ann Neurol"},{"key":"1096_CR84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC et al (2004) The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-013-1096-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1096-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T20:14:02Z","timestamp":1714940042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-013-1096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s00401-013-1096-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]}}}